STIM1 elevation in the heart results in aberrant Ca2 + handling and cardiomyopathy. (October 2015)

• Record Type: Journal Article
• Authors: Correll, Robert N.; Goonasekera, Sanjeewa A.; van Berlo, Jop H.; Burr, Adam R.; Accornero, Federica; Zhang, Hongyu; Makarewich, Catherine A.; York, Allen J.; Sargent, Michelle A.; Chen, Xiongwen; Houser, Steven R.; Molkentin, Jeffery D.
• Is Part Of: Journal of molecular and cellular cardiology. Volume 87(2015:Oct.)
• Page Start: 38
• Page End: 47
• Publication Date: 2015-10
• Subjects: AngII angiotensin II -- BDM 2, 3-butanedione monoxime -- CaMKII Ca2 +/calmodulin-dependent protein kinase II -- CMF Ca2 +- and Mg2 +-free Ringer's solution -- CPA cyclopiazonic acid -- EC excitation–contraction -- ER endoplasmic reticulum -- LTCC L-type Ca2 + channel -- NFAT nuclear factor of activated T-cells -- PE phenylephrine -- RyR ryanodine receptor -- SERCA2 sarcoplasmic/endoplasmic reticulum Ca2 + ATPase 2 -- SOCE store-operated Ca2 + entry -- SR sarcoplasmic reticulum -- STIM1 stromal interaction molecule 1 -- TAC transverse aortic constriction -- TG transgenic -- TRP transient receptor potential -- Wt wild-type; Calcium -- Hypertrophy -- Cardiac myocytes -- Heart failure -- Transgenesis; Cardiology -- Periodicals; Heart Diseases -- Periodicals; Molecular Biology -- Periodicals; Cardiologie -- Périodiques; Cardiology; Electronic journals; Periodicals; 616.12
• DOI: 10.1016/j.yjmcc.2015.07.032
• Languages: English
• ISSNs: 0022-2828

Abstract

Abstract: Stromal interaction molecule 1 (STIM1) is a Ca 2 + sensor that partners with Orai1 to elicit Ca 2 + entry in response to endoplasmic reticulum (ER) Ca 2 + store depletion. While store-operated Ca 2 + entry (SOCE) is important for maintaining ER Ca 2 + homeostasis in non-excitable cells, it is unclear what role it plays in the heart, although STIM1 is expressed in the heart and upregulated during disease. Here we analyzed transgenic mice with STIM1 overexpression in the heart to model the known increase of this protein in response to disease. As expected, STIM1 transgenic myocytes showed enhanced Ca 2 + entry following store depletion and partial co-localization with the type 2 ryanodine receptor (RyR2) within the sarcoplasmic reticulum (SR), as well as enrichment around the sarcolemma. STIM1 transgenic mice exhibited sudden cardiac death as early as 6 weeks of age, while mice surviving past 12 weeks of age developed heart failure with hypertrophy, induction of the fetal gene program, histopathology and mitochondrial structural alterations, loss of ventricular functional performance and pulmonary edema. Younger, pre-symptomatic STIM1 transgenic mice exhibited enhanced pathology following pressure overload stimulation or neurohumoral agonist infusion, compared to controls. Mechanistically, cardiac myocytes isolated from STIM1 transgenic mice displayed spontaneous Ca 2 + transients that were prevented by the SOCE blocker SKF-96365, increased L-type Ca 2 + channel (LTCC) current, and enhanced Ca 2 + spark frequency. Moreover, adult cardiac myocytes from STIM1 transgenic mice showed both increased diastolic Ca 2 + and maximal transient amplitude but no increase in total SR Ca 2 + load. Associated with this enhanced Ca 2 + profile was an increase in cardiac nuclear factor of activated T-cells (NFAT) and Ca 2 + /calmodulin-dependent kinase II (CaMKII) activity. We conclude that STIM1 has an unexpected function in the heart where it alters communication between the sarcolemma and SR resulting in greater Ca 2 + flux and a leaky SR compartment. Highlights: STIM1 transgenic mice showed increased Ca 2 + entry following store depletion. STIM1 transgenic mice develop cardiac hypertrophy and sudden death. Mitochondrial structure is compromised in STIM1 transgenic mouse hearts. STIM1 transgenic mice are predisposed to increased disease following insult. Myocytes isolated from STIM1 transgenic mice have elevated spark frequency.